| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nektar Therapeutics (NKTR) has 8 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. NKTR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 75.9K | $4.84M | - | |
| Other | 21.6K | $1.38M | - | |
| Other | 15.4K | $983.9K | -5,538 | |
| Dir | 8.0K | $509.9K | - | |
| Dir | 8.0K | $509.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2016 | Nicholson John | SVP &Chief Operating Officer | Sell | 1,654 | $13.96 | $23,089.84 | -1.4% | |
| Nov 16, 2016 | Labrucherie Gil M84 | SVP &Chief Financial Officer | Sell | 1,654 | $13.96 | $23,089.84 | -3.1% | |
| Nov 16, 2016 | Hora Maninder | SVP Pharma Dev &Mfg Ops | Sell | 1,654 | $13.96 | $23,089.84 | -3.2% | |
| Nov 16, 2016 | Gergel Ivan P. | SVP &Chief Medical Officer | Sell | 848 | $13.96 | $11,838.08 | -3.1% | |
| Nov 16, 2016 | Doberstein Stephen K | SVP &Chief Scientific Officer | Sell | 670 | $13.96 | $9,353.20 | -3.5% | |
| Oct 24, 2016 | Greer R Scott | Director | Buy | 15,000 | $13.50 | $202,500.00 | +14.1% | |
| Oct 4, 2016 | Robin Howard W58 | President &CEO | Sale+OE | 87,500 | $17.06 | $1,492,750.00 | -40.4% | |
| Sep 16, 2016 | Kuebler Christopher A58 | Director | Sale+OE | 7,500 | $19.13 | $143,475.00 | -21.4% | |
| Sep 15, 2016 | Chess Robert84 | Director | Sale+OE | 12,000 | $19.21 | $230,520.00 | -4.6% | |
| Sep 15, 2016 | Lingnau Lutz | Director | Sale+OE | 9,000 | $19.06 | $171,540.00 | -54.7% |